Blogs
Explore the innovations shaping safer cell and gene therapies
The Off-Target Problem the Gene Editing Industry Can No Longer Afford to Ignore
Gene editing has changed dramatically over the last decade. Early innovation focused on proving technologies such as CRISPR could edit DNA accurately enough to become viable therapeutic tools.

